Coronary Vasomotor Dysfunction Is Associated With Cardiovascular Events in Patients With Nonobstructive Coronary Artery Disease

• Published in: JACC. Cardiovascular interventions Vol. 17; no. 4; pp. 474 - 487
• Main Authors: Kanaji, Yoshihisa, Ahmad, Ali, Sara, Jaskanwal Deep Singh, Ozcan, Ilke, Akhiyat, Nadia, Prasad, Abhiram, Raphael, Claire E., Kakuta, Tsunekazu, Lerman, Lilach O., Lerman, Amir
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 26.02.2024
• Subjects: Acetylcholine; Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; coronary vasomotor dysfunction; Coronary Vessels - diagnostic imaging; Endothelium, Vascular; endothelium-dependent dysfunction; endothelium-independent dysfunction; Humans; microvascular dysfunction; nonobstructive coronary artery disease; Treatment Outcome; NTG; CRT; CBF; Ach; APV; endothelium-independent dysfunction; ΔCBF-Ach; MACCE; HFpEF; CFR; LAD; ΔCSA-NTG; microvascular dysfunction; nonobstructive coronary artery disease; endothelium-dependent dysfunction; CV; CVDys; FFR; MACE; ANOCA; coronary vasomotor dysfunction; MI; ΔCAD-Ach
• DOI: 10.1016/j.jcin.2023.11.039
• ISSN: 1936-8798

Coronary vasomotor dysfunction (CVDys) can be comprehensively classified on the basis of anatomy and functional mechanisms. The aim of this study was to evaluate the association between different CVDys phenotypes and outcomes in patients with angina and nonobstructive coronary artery disease (ANOCA). Patients with ANOCA who underwent coronary reactivity testing using an intracoronary Doppler guidewire to assess microvascular and epicardial coronary endothelium-dependent and endothelium-independent function were enrolled. Endothelium-dependent microvascular and epicardial coronary dysfunction were defined as a <50% change in coronary blood flow in response to intracoronary acetylcholine (Ach) infusion and a <−20% change in coronary artery diameter in response to Ach. Endothelium-independent microvascular and epicardial coronary dysfunction were defined as coronary flow reserve < 2.5 during adenosine-induced hyperemia and change in cross-sectional area in response to intracoronary nitroglycerin administration < 20%. Major adverse cardiac and cerebrovascular events (cardiovascular death, nonfatal MI, heart failure, stroke, and late revascularization) served as clinical outcomes. Among the 1,196 patients with ANOCA, the prevalence of CVDys was 24.5% and 51.8% among those with endothelium-independent and endothelium-dependent microvascular dysfunction, respectively, and 47.4% and 25.4% among those with endothelium-independent and endothelium-dependent epicardial coronary dysfunction, respectively. During 6.3 years (Q1-Q3: 2.5-12.9 years) of follow-up, patients with endothelium-dependent microvascular dysfunction, endothelium-dependent epicardial coronary dysfunction, or endothelium-independent microvascular dysfunction showed significantly higher event rates compared with those without (19.5% vs 12.0% [P < 0.001], 19.7% vs 14.6% [P = 0.038] and 22.2% vs 13.8% [P = 0.001], respectively). Coronary flow reserve (HR: 0.757; 95% CI: 0.604-0.957) and percentage change in coronary blood flow in response to Ach infusion (HR: 0.998; 95% CI: 0.996-0.999) remained significant predictors of major adverse cardiac and cerebrovascular event after adjustment for conventional risk factors. CVDys phenotype is differentially associated with worse outcomes, and endothelium-dependent and endothelium-independent microvascular function provide independent prognostic information in patients with ANOCA. [Display omitted]